pivalyloxymethyl butyrate has been researched along with Lung Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatnagar, A; Irwin, D; Keer, H; Lipera, W; Lum, B; Natale, R; Paroly, W; Reid, T; Scappaticci, F; Sreedharan, S; Valone, F | 1 |
| Gridelli, C; Maione, P; Rossi, A | 1 |
| Honma, Y; Kasukabe, T; Niitsu, N; Okabe-Kado, J; Umeda, M; Yamamoto-Yamaguchi, Y; Yokoyama, A | 1 |
| Aviram, A; Nudelman, A; Rabizadeh, E; Rephaeli, A; Ruse, M; Shaklai, M | 1 |
1 review(s) available for pivalyloxymethyl butyrate and Lung Neoplasms
| Article | Year |
|---|---|
The potential role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Butyrates; Carcinoma, Non-Small-Cell Lung; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Indoles; Lung Neoplasms; Panobinostat; Phenylenediamines; Vorinostat | 2008 |
1 trial(s) available for pivalyloxymethyl butyrate and Lung Neoplasms
| Article | Year |
|---|---|
Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Butyrates; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Fatigue; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Nausea; Survival Analysis | 2004 |
2 other study(ies) available for pivalyloxymethyl butyrate and Lung Neoplasms
| Article | Year |
|---|---|
Anticancer derivative of butyric acid (Pivalyloxymethyl butyrate) specifically potentiates the cytotoxicity of doxorubicin and daunorubicin through the suppression of microsomal glycosidic activity.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport; Butyrates; Cell Cycle; Cell Division; Daunorubicin; DNA; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Glycoside Hydrolases; Humans; Lung Neoplasms; Lymphoma; Microsomes; Oligonucleotides, Antisense; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Derivatives of butyric acid as potential anti-neoplastic agents.
Topics: Animals; Antineoplastic Agents; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Mice; Prodrugs; Survival Analysis; Tumor Cells, Cultured | 1991 |